OVID
OVID
NASDAQ · Biotechnology

Ovid Therapeutics Inc

$2.40
-0.14 (-5.51%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +1,610.0% upside
Low Target $30.97
Average Target $41.04
High Target $66.83
Current Price $2.40
Current
$2.40
Target
$41.04
$30.97 $41.04 avg $66.83
Scenario Analysis
Bear Case
$30.97
1,190.4%
Low target
Base Case
$41.04
+1,610.0%
Avg target
Bull Case
$66.83
+2,684.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.11
-22.7% from high
52-Week Low
$1.18
+103.4% from low
50-Day SMA
$2.50
-4.0% vs SMA
200-Day SMA
$2.42
-0.8% vs SMA
RSI (14)
54.1
Neutral
Target vs 52W High
$41.04
+1,221.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%